$185.00 Original price was: $185.00.$9.00Current price is: $9.00.
Epigenetic Cancer Therapy, Second Edition, is a groundbreaking publication that delves into the intricacies of healthy and aberrant epigenetic biology. This comprehensive guide provides insights into new discoveries that have significantly enhanced our understanding of cancer epigenetics and therapeutics. It covers large-scale intergovernmental initiatives, recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies.
The book serves as a testament to the evolving landscape of epigenetics, highlighting its potential as a therapeutic option in the future management of cancer. Since the publication of the first edition, the field of epigenetics has witnessed substantial growth, with new epigenetic therapies being designed and approved for clinical use. Moreover, our knowledge of the epigenome’s plasticity in cancer and disease has expanded dramatically, with increasing evidence linking pollution to epigenetic changes in cancer development.
This second edition has been fully updated to address these changes, including promising therapeutic programs such as CRISPR/Cas9 mediated approaches, CAR-T based therapies, epigenetic priming, histone modifications, and similar transformative advances across synthetic biology and cellular engineering. It provides a detailed overview of the following topics:
Epigenetic Cancer Therapy, Second Edition, is an indispensable resource for researchers, scientists, and healthcare professionals seeking to understand the complex interplay between epigenetics and cancer. It offers a comprehensive and up-to-date overview of the field, making it an essential read for those interested in the future of cancer management.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline